VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 2 filers reported holding VYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $63,014 | +34.1% | 420,092 | +100.0% | 0.00% | – |
| Q3 2022 | $47,000 | -42.7% | 210,046 | 0.0% | 0.00% | – |
| Q2 2022 | $82,000 | -38.3% | 210,046 | +3.0% | 0.00% | – |
| Q1 2022 | $133,000 | -76.0% | 203,846 | -62.5% | 0.00% | – |
| Q4 2021 | $555,000 | -26.6% | 544,013 | 0.0% | 0.00% | – |
| Q3 2021 | $756,000 | -59.7% | 544,013 | +1.8% | 0.00% | – |
| Q2 2021 | $1,876,000 | -71.4% | 534,613 | -44.3% | 0.00% | – |
| Q1 2021 | $6,566,000 | – | 959,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 450,000 | $1,580,000 | 3.15% |
| DSC Advisors, L.P. | 1,100,000 | $3,861,000 | 2.79% |
| CM Management, LLC | 143,750 | $505,000 | 0.36% |
| Perceptive Advisors | 11,547,908 | $40,534,000 | 0.26% |
| DELTEC ASSET MANAGEMENT LLC | 386,491 | $1,357,000 | 0.19% |
| Tibra Equities Europe Ltd | 91,000 | $319,000 | 0.10% |
| 683 Capital Management, LLC | 733,683 | $2,575,000 | 0.09% |
| Banque Cantonale Vaudoise | 200,000 | $702,000 | 0.03% |
| Platform Technology Partners | 15,832 | $56,000 | 0.02% |
| Tekla Capital Management LLC | 135,395 | $475,000 | 0.02% |